Biocardia Inc (BCDA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,259 | -8,228 | -6,244 | -4,761 | -2,712 |
| Depreciation Amortization | 3 | 24 | 21 | 17 | 12 |
| Accounts receivable | N/A | -20 | N/A | -10 | N/A |
| Other Working Capital | 363 | -143 | 640 | 1,013 | 791 |
| Other Operating Activity | 234 | 931 | 644 | 474 | 291 |
| Operating Cash Flow | $-1,659 | $-7,436 | $-4,939 | $-3,267 | $-1,618 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -3 | -7 | -1 | -1 | N/A |
| Investing Cash Flow | $-3 | $-7 | $-1 | $-1 | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 225 | 8,690 | 8,690 | 1,907 | 212 |
| Other Financing Activity | -108 | -1,122 | -834 | -30 | -16 |
| Financing Cash Flow | $117 | $7,568 | $7,856 | $1,877 | $196 |
| Beginning Cash Position | 2,496 | 2,371 | 2,371 | 2,371 | 2,371 |
| End Cash Position | 951 | 2,496 | 5,287 | 980 | 949 |
| Net Cash Flow | $-1,545 | $125 | $2,916 | $-1,391 | $-1,422 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,659 | -7,436 | -4,939 | -3,267 | -1,618 |
| Capital Expenditure | -3 | -7 | -1 | -1 | N/A |
| Free Cash Flow | -1,662 | -7,443 | -4,940 | -3,268 | -1,618 |